News
Biotech partnership formed to examine vaccine production feasibility in Missoula
November 20, 2011 /
A new biotech partnership has formed in Missoula to examine whether the niche area of vaccine production could become an economic driver here.
The Missoula Vaccine Partnership will explore the possibility of developing a regional center of excellence for vaccine production. A $25,000 Big Sky Trust Fund grant was awarded to the project last week to help study the concept’s feasibility.
"What we’re trying to do is understand, can it be done here?" Rocky Mountain Biologicals president Suresh Daniel said.
By JENNA CEDERBERG of the Missoulian
MATR Supporters (view all)
Posted in: Biotech
Sorry, we couldn't find any posts. Please try a different search.